Clinical characteristics of 144 pediatric patients with B-other ALL registered at the Boldrini Children’s Center who were included in this study
| . | B-other features . |
|---|---|
| Total of B-other analyzed | 144 |
| Treatment protocol | |
| GBTLI LLA-1999 | 86 |
| GBTLI LLA-2009 | 58 |
| Age at diagnosis (y)∗ | |
| Median | 7.38 |
| Range | 0.28-17.85 (average 8.36) |
| Sex, n (%) | |
| Male | 80 (55.6) |
| Female | 64 (44.4) |
| WBC count at diagnosis (x 109/L) | |
| Median | 20.9 |
| Range | 1.3-459.0 |
| WBC count at risk | |
| <50 × 109/L | 97 |
| ≥50 × 109/L | 47 |
| NCI risk at diagnosis, n (%) | |
| Standard risk | 124 (86.1) |
| High risk | 20 (13.9) |
| . | B-other features . |
|---|---|
| Total of B-other analyzed | 144 |
| Treatment protocol | |
| GBTLI LLA-1999 | 86 |
| GBTLI LLA-2009 | 58 |
| Age at diagnosis (y)∗ | |
| Median | 7.38 |
| Range | 0.28-17.85 (average 8.36) |
| Sex, n (%) | |
| Male | 80 (55.6) |
| Female | 64 (44.4) |
| WBC count at diagnosis (x 109/L) | |
| Median | 20.9 |
| Range | 1.3-459.0 |
| WBC count at risk | |
| <50 × 109/L | 97 |
| ≥50 × 109/L | 47 |
| NCI risk at diagnosis, n (%) | |
| Standard risk | 124 (86.1) |
| High risk | 20 (13.9) |
One patient with outlier age (21 years) was registered and treated within the GBLTI-1999.